证券代码：603605 证券简称：珀莱雅 公告编号：2025-041 债券代码：113634 债券简称：珀莱转债 珀莱雅化妆品股份有限公司 关于第四届监事会第五次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 珀莱雅化妆品股份有限公司（以下简称"公司"）第四届监事会第五次会议 通知于 2025 年 8 月 15 日以电子邮件方式送达全体监事，本次会议于 2025 年 8 月 25 日在公司会议室以现场方式召开。本次会议由监事会主席侯露婷女士主持， 会议应出席监事 3 人，实际出席监事 3 人。本次监事会会议的召集、召开符合《中 华人民共和国公司法》（以下简称"《公司法》"）、《珀莱雅化妆品股份有限 公司章程》（以下简称"《公司章程》"）的有关规定，决议内容合法有效。 二、监事会会议审议情况 （一）审议通过《公司 2025 年半年度报告及其摘要》 监事会认为： （1）公司严格按照会计准则规范运作，《公司 2025 年半年度报告》全文及 其摘要公允地反映了 2025 年半年度的财务状况和经营 ...

证券代码：603605 证券简称：珀莱雅 公告编号：2025-049 债券代码：113634 债券简称：珀莱转债 珀莱雅化妆品股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (二)股东大会召集人：董事会 召开的日期时间：2025 年 9 月 11 日 14 点 30 分 召开地点：杭州市西湖区西溪路 588 号珀莱雅大厦 9 楼会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 (七)涉及公开征集股东投票权 无 二、 会议审议事项 本次股东大会审议议案及投票股东类型 投票股东类型 网络投票起止时间：自2025 年 9 月 11 日 至2025 年 9 月 11 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通 过互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 ( ...

Core Viewpoint - The company has announced its 2025 "Quality Improvement and Efficiency Enhancement" action plan, focusing on enhancing operational quality, increasing investor returns, and accelerating the development of new productive forces [1][3][5]. Group 1: Enhancing Operational Quality - The company is committed to steady operations and strengthening strategic execution to improve operational quality and core competitiveness, while advancing digital transformation [1]. - The company has established a diversified brand matrix and omnichannel layout, optimizing its core product offerings to enhance brand, product, and technological strength [2]. - The main brand, "Polaire," focuses on consumer needs, launching innovative products in response to high-growth demands and trends in medical aesthetics [2]. Group 2: Increasing Investor Returns - The company emphasizes a stable profit distribution policy, having distributed a total of 1.81 billion yuan in cash dividends from 2017 to 2024, with annual dividends exceeding 30% of net profit [3]. - The company plans to distribute a cash dividend of 1.19 yuan per share, totaling approximately 468.90 million yuan, which represents 39.48% of the net profit for the first half of 2025 [4]. Group 3: Accelerating Development of New Productive Forces - The company is focused on technological innovation, establishing a complete innovation chain from basic research to clinical application, and enhancing its global R&D system [5]. - As of June 30, 2025, the company holds 124 national invention patents and has successfully applied various innovations in its product lines [5]. Group 4: Strengthening Investor Communication - The company is enhancing investor communication through various channels, including regular performance briefings and interactive platforms, to address investor concerns and improve understanding [6]. - The company has committed to high-quality information disclosure, continuously optimizing the content and transparency of its disclosures [6]. Group 5: Ensuring Compliance and Governance - The company is improving its internal control systems and governance structure to enhance decision-making and operational compliance [7]. - The company is focusing on the responsibilities of key personnel, ensuring they are well-informed about regulatory updates and enhancing their compliance awareness [8]. Group 6: Ongoing Evaluation and Commitment - The company will continue to evaluate the specific measures of the "Quality Improvement and Efficiency Enhancement" action plan and fulfill its disclosure obligations [8].

Group 1 - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance overseas business development [1][2] - The board of directors approved the proposal on August 25, 2025, and the issuance is subject to further approvals from regulatory bodies [1][2] - The details of the issuance are still under discussion with relevant intermediaries, and there is significant uncertainty regarding the approval and implementation of the issuance [2] Group 2 - The issuance will not result in changes to the company's controlling shareholder or actual controller [2] - The company will fulfill its information disclosure obligations in accordance with legal regulations based on the progress of the issuance [2]

Group 1 - Zhejiang Wenying's independent director Liu Jing has been detained by relevant supervisory authorities, but the matter is unrelated to the company, and operations remain normal [3] - China Petroleum plans to acquire 100% equity of three gas storage companies for a total consideration of RMB 40.016 billion, with specific amounts for each storage facility detailed [4] - Beiyi Micro plans to acquire 100% equity of Shanghai Xinggan Semiconductor for RMB 2.95 billion, with the transaction not constituting a major asset restructuring [5] Group 2 - Dongzhu Ecology is planning to acquire controlling stakes in Kai Rui Xing Tong through a combination of share issuance and cash payment, with the stock expected to be suspended for up to 10 trading days [6] - Nanxin Pharmaceutical intends to acquire a group of assets from Future Pharmaceuticals, which is expected to constitute a major asset restructuring [7] - Xinhua Jin has received a regulatory notice regarding the non-operational occupation of company funds amounting to RMB 406 million, which may lead to risk warnings and potential delisting if not resolved [8] Group 3 - Dongjie Intelligent's actual controller will change to individual Han Yongguang after a transfer of fund shares valued at RMB 1.62 billion, with stock resuming trading on August 27, 2025 [9] - Sentec announced that it does not engage in "data center" related businesses, clarifying its focus on BIPV and other construction-related sectors [10] - Cambridge Technology stated it currently does not produce chips containing CPO technology, with related projects still in the development phase [11] Group 4 - Proya is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [12] - Northern Rare Earth reported a net profit of RMB 931 million for the first half of 2025, a year-on-year increase of 1951.52% [13] - Cambrian Technology achieved a net profit of RMB 1.038 billion in the first half of 2025, marking a significant turnaround from a loss in the previous year [14] Group 5 - Shenghong Technology reported a net profit of RMB 2.143 billion for the first half of 2025, reflecting a year-on-year growth of 366.89% [15] - Inspur Information's net profit for the first half of 2025 was RMB 799 million, up 34.87% year-on-year [17] - China Petroleum's net profit for the first half of 2025 decreased by 5.4% to RMB 84.01 billion, with revenue down 6.7% [18] Group 6 - Ping An Insurance reported a net profit of RMB 68.047 billion for the first half of 2025, a decline of 8.8% year-on-year [19] - China Duty Free Group's net profit for the first half of 2025 was RMB 2.6 billion, down 20.81% year-on-year [21] - Zijin Mining reported a net profit of RMB 23.292 billion for the first half of 2025, an increase of 54.41% year-on-year [22]

Core Viewpoint - The company Proya, a leading domestic beauty brand, is planning to issue H-shares and list on the Hong Kong Stock Exchange to boost its capital amid slowing growth rates in revenue and net profit [2][5][6]. Financial Performance - Proya's revenue for the first half of 2025 increased by 7.21% to 5.362 billion yuan, while net profit rose by 13.80% to 799 million yuan [3][5]. - The sales net profit margin improved to 15.41%, and the gross profit margin was 73.38% [3][5]. - The highest growth was seen in the hair care category, which surged by 131.25%, while the beauty makeup category grew by 25.79% [3][4]. Dividend Announcement - Proya announced a record cash dividend plan, proposing a distribution of 8 yuan per 10 shares, totaling approximately 315 million yuan [4][5]. - This dividend represents nearly 40% of Proya's net profit for the first half of 2025, bringing the total dividends since its listing in 2017 to over 2.1 billion yuan [5]. H-Share Listing Plans - The company is planning to issue H-shares to enhance its capital strength and competitiveness, aiming for international capital and brand recognition [5][6]. - The potential benefits of listing in Hong Kong include opportunities for capital internationalization, governance standardization, and global brand expansion [5][6]. Market Competition and Growth Potential - Despite being a leader in the domestic skincare market, Proya faces intense competition from international brands and emerging domestic brands [7]. - The global cosmetics market is projected to reach $446.43 billion by 2025, with a compound annual growth rate of 5.5%, indicating significant growth opportunities for Proya in overseas markets [7].

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company's performance met expectations, with profit growth outpacing revenue growth. In H1 2025, total revenue reached 5.362 billion yuan (up 7.21% YoY), and net profit attributable to shareholders was 799 million yuan (up 13.80% YoY) [7] - The company is planning a Hong Kong stock listing to accelerate international development and enhance overseas financing capabilities [7] - The new management strategy has shown initial results, with over 10 new products launched in the first half of 2025, expanding into new categories such as whitening and medical beauty [7] Financial Summary - Total revenue projections for 2025 are estimated at 11.854 billion yuan, with a YoY growth rate of 10.0% [6] - The net profit attributable to shareholders is projected to be 1.756 billion yuan in 2025, reflecting a YoY growth rate of 13.1% [6] - The gross margin for H1 2025 was reported at 73.4%, an increase of 3.6 percentage points YoY, while the net profit margin was 15.4%, up 0.9 percentage points YoY [7]

Core Viewpoint - The company reported a revenue of 5.362 billion yuan for the first half of 2025, representing a year-on-year growth of approximately 7.21%, and a net profit attributable to shareholders of 799 million yuan, reflecting a year-on-year increase of about 13.80% [1][4]. Group 1: Financial Performance - The company achieved a revenue of 5.362 billion yuan in the first half of 2025, which is a year-on-year increase of approximately 7.21% [1][4]. - The net profit attributable to shareholders reached 799 million yuan, marking a year-on-year growth of about 13.80% [1][4]. - The company plans to distribute a cash dividend of 8 yuan per 10 shares (including tax), amounting to a total cash dividend of approximately 315 million yuan [1][4]. Group 2: Business Strategy and Operations - The revenue growth in the first half of the year was primarily driven by an increase in online channel sales [4]. - The company is focused on building a new domestic cosmetics industry platform, engaging in the research, production, and sales of cosmetic products under various brands [5]. - The company operates mainly through online channels, utilizing direct sales and distribution models on platforms such as Tmall, Douyin, JD.com, Kuaishou, and Pinduoduo, while also maintaining offline sales through distributors [5]. Group 3: Market Activity - On August 26, the company's stock price increased by 3.9%, closing at 91.99 yuan per share, with a total market capitalization of 36.429 billion yuan [5]. - The company announced plans to issue overseas listed shares (H-shares) and list on the Hong Kong Stock Exchange, with discussions ongoing regarding the details of the issuance [5].

北京商报讯（记者 张君花）8月26日，珀莱雅发布2025年上半年财报称，公司上半年实现营业收入53.62 亿元，同比增长7.21%；归属于上市公司股东的净利润7.99亿元，同比增长13.8%。 ...

Core Viewpoint - The company, Proya, announced its plan to issue overseas listed shares (H-shares) and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance its overseas business development [1] Group 1: Company Strategy - The issuance aims to strengthen the company's overseas financing capabilities and improve its overall competitiveness [1] - The company is currently in discussions with relevant intermediaries regarding the details of the issuance, which have not yet been finalized [1] Group 2: Shareholder Impact - The issuance will not result in any changes to the company's controlling shareholders or actual controllers [1]